articleArchives of General PsychiatryNov 1, 2003Closed access

Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

Eli Lilly (United States) · Harvard University Press · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

Despite the longer duration of the depressive phase in bipolar disorder and the frequent clinical use of antidepressants combined with antipsychotics or mood stabilizers, relatively few controlled studies have examined treatment strategies for bipolar depression.

Objective

To examine the use of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

Citation impact

908
total citations
FWCI
35.86
Percentile
100%
References
52
Citations per year

Authors

15

Topics & keywords

Keywords
  • Olanzapine
  • Fluoxetine
  • Mania
  • Young Mania Rating Scale
  • Placebo
  • Psychology
  • Randomized controlled trial
  • Psychiatry
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding